KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph)

**Product type:** Human Prescription Drug

**Active ingredient:** BERAHYALURONIDASE ALFA; PEMBROLIZUMAB

**Strength:** 2000; 165 U/mL; mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Merck Sharp & Dohme LLC

**Marketing category:** BLA (BLA761467)

**Pharmacologic class:** Endoglycosidase [EPC], Glycoside Hydrolases [CS], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]